Ketotifen fumarate ophthalmic - Novartis Ophthalmics
Alternative Names: Zaditen; Zaditor; ZatidenLatest Information Update: 27 Apr 2024
At a glance
- Originator Novartis Ophthalmics
- Class Antiallergics; Eye disorder therapies; Piperidines; Sedating antihistamines; Small molecules; Thiophenes
- Mechanism of Action Histamine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Allergic conjunctivitis
Most Recent Events
- 23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
- 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
- 18 Oct 2004 Launched as a 0.05% formulation for Allergic conjunctivitis in Japan (Ophthalmic)